Meghan Fitzgerald
CIK: 0001349297
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (20 total)
- Sep 16, 2026ROIV
Roivant Sciences Ltd.
Award(A)Direct5.1K shares- - Sep 15, 2026ROIV
Roivant Sciences Ltd.
Sale(S)Direct400 shares at avg. $40.45$16K - Sep 15, 2026ROIV
Roivant Sciences Ltd.
Sale(S)Direct4.7K shares at avg. $39.68$187K - Sep 10, 2026ROIV
Roivant Sciences Ltd.
Tax Payment(F)Direct1.7K shares at avg. $40.94$71K - Sep 8, 2026ROIV
Roivant Sciences Ltd.
Exercise(M)Direct20K shares at avg. $8.80$176K - Sep 8, 2026ROIV
Roivant Sciences Ltd.
Sale(S)Direct20K shares at avg. $39.90$798K - Jun 30, 2026ROIV
Roivant Sciences Ltd.
Sale(S)Direct10K shares at avg. $34.90$349K - Jun 30, 2026ROIV
Roivant Sciences Ltd.
Exercise(M)Direct10K shares at avg. $8.80$88K - May 27, 2026THC
TENET HEALTHCARE CORP
Award(A)Direct2026 May Restricted Stock Units
1.2K shares- - May 22, 2026THC
TENET HEALTHCARE CORP
Disposition(D)Direct493 shares at avg. $173.78$86K - May 22, 2026THC
TENET HEALTHCARE CORP
Exercise(M)Direct1.3K shares- - Mar 26, 2026ROIV
Roivant Sciences Ltd.
Exercise(M)Direct70K shares at avg. $8.80$616K - Mar 26, 2026ROIV
Roivant Sciences Ltd.
Sale(S)Direct70K shares at avg. $27.45$1.9M - Sep 10, 2025ROIV
Roivant Sciences Ltd.
Other(J)Direct937 shares at avg. $13.77$13K - Sep 10, 2025ROIV
Roivant Sciences Ltd.
Award(A)Direct14.5K shares- - May 23, 2025THC
TENET HEALTHCARE CORP
Exercise(M)Direct1.6K shares- - May 23, 2025THC
TENET HEALTHCARE CORP
Disposition(D)Direct573 shares at avg. $161.33$92K - May 22, 2025THC
TENET HEALTHCARE CORP
Award(A)DirectRestricted Stock Units
1.3K shares- - Sep 12, 2024ROIV
Roivant Sciences Ltd.
Other(J)Direct894 shares at avg. $12.12$11K - Sep 10, 2024ROIV
Roivant Sciences Ltd.
Award(A)Direct16.4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 16, 2026 |  ROIV Roivant Sciences Ltd. | Award(A) | 5,054 | - | $0 | Direct |
| Sep 15, 2026 | ROIV Roivant Sciences Ltd. | Sale(S) | 400 | $40.45 | $16,180 | Direct |
| Sep 15, 2026 | ROIV Roivant Sciences Ltd. | Sale(S) | 4,712 | $39.68 | $186,972 | Direct |
| Sep 10, 2026 | ROIV Roivant Sciences Ltd. | Tax Payment(F) | 1,743 | $40.94 | $71,358 | Direct |
| Sep 8, 2026 | ROIV Roivant Sciences Ltd. | Exercise(M) | 20,000 | $8.80 | $176,000 | Direct |
| Sep 8, 2026 | ROIV Roivant Sciences Ltd. | Sale(S) | 20,000 | $39.90 | $798,000 | Direct |
| Jun 30, 2026 | ROIV Roivant Sciences Ltd. | Sale(S) | 10,000 | $34.90 | $349,000 | Direct |
| Jun 30, 2026 | ROIV Roivant Sciences Ltd. | Exercise(M) | 10,000 | $8.80 | $88,000 | Direct |
| May 27, 2026 |  THC TENET HEALTHCARE CORP | Award(A) 2026 May Restricted Stock Units | 1,188 | - | - | Direct |
| May 22, 2026 | THC TENET HEALTHCARE CORP | Disposition(D) | 493 | $173.78 | $85,674 | Direct |
| May 22, 2026 | THC TENET HEALTHCARE CORP | Exercise(M) | 1,333 | - | $0 | Direct |
| Mar 26, 2026 | ROIV Roivant Sciences Ltd. | Exercise(M) | 70,000 | $8.80 | $616,000 | Direct |
| Mar 26, 2026 | ROIV Roivant Sciences Ltd. | Sale(S) | 70,000 | $27.45 | $1,921,500 | Direct |
| Sep 10, 2025 | ROIV Roivant Sciences Ltd. | Other(J) | 937 | $13.77 | $12,902 | Direct |
| Sep 10, 2025 | ROIV Roivant Sciences Ltd. | Award(A) | 14,524 | - | - | Direct |
| May 23, 2025 | THC TENET HEALTHCARE CORP | Exercise(M) | 1,551 | - | - | Direct |
| May 23, 2025 | THC TENET HEALTHCARE CORP | Disposition(D) | 573 | $161.33 | $92,442 | Direct |
| May 22, 2025 | THC TENET HEALTHCARE CORP | Award(A) Restricted Stock Units | 1,333 | - | - | Direct |
| Sep 12, 2024 | ROIV Roivant Sciences Ltd. | Other(J) | 894 | $12.12 | $10,835 | Direct |
| Sep 10, 2024 | ROIV Roivant Sciences Ltd. | Award(A) | 16,406 | - | $0 | Direct |
1-20 of 20 transactions
About Fitzgerald Meghan
Fitzgerald Meghan (SEC CIK 0001349297) files insider reports with the SEC as Director of Roivant Sciences Ltd. (ROIV) and Director of TENET HEALTHCARE CORP (THC).
Signal8 holds 12 ownership filings by Fitzgerald Meghan, all Form 4s, filed between Sep 12, 2024 and Sep 18, 2026. Those filings report 20 transactions, from Sep 10, 2024 to Sep 16, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Fitzgerald Meghan's filings is in LONDON.
Recent filings by Fitzgerald Meghan
- Sep 16, 2026: Grant or award of ROIV shares (Form 4, code A).
- Sep 15, 2026: Open-market sales of ROIV shares (2 lines, Form 4, code S).
- Sep 10, 2026: Tax withholding of ROIV shares (Form 4, code F).
- Sep 8, 2026: Option exercise of ROIV shares (Form 4, code M).
- Sep 8, 2026: Open-market sale of ROIV shares (Form 4, code S).
Other insiders filing for Roivant Sciences Ltd. (ROIV)
- Venker Eric, President & Immunovant CEO
- Oren Ilan, Director
- Epperly Melissa B,, Director
- MOMTAZEE JAMES C, Director
- Sukhatme Mayukh, President & CIO
- Gline Matthew, CEO